James R. Berenson

Statistics

Publications

166

Citations

18.6K

H-Index

Active since

1967

Affiliations

Institute for Myeloma & Bone Cancer Research(Current)

Oncotherapeutics (United States)

Cedars-Sinai Medical Center

University of California, Los Angeles

West Los Angeles College

James R. Berenson is an author at Institute for Myeloma & Bone Cancer Research specializing in medicine, multiple myeloma, and multiple myeloma treatment.

ORCID

Publications per year

1967–2022

166

Publications

166

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

James R. Berenson, Alan Lichtenstein, Lester Porter et al. · New England Journal of Medicine · 1996 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +16

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

Sundar Jagannath, Bart Barlogie, James R. Berenson et al. · British Journal of Haematology · 2004 · 740 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

James R. Berenson, Alan Lichtenstein, Lisa A. Porter et al. · Journal of Clinical Oncology · 1998 · 653 citations

Medicine, Pharmacology, Pharmacotherapy +14

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Paul G. Richardson, Hannah Briemberg, Sundar Jagannath et al. · Journal of Clinical Oncology · 2006 · 650 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

1–5 of 166